The largest database of trusted experimental protocols

Yy1 sirna

Manufactured by GenePharma
Sourced in China

YY1 siRNA is a laboratory reagent designed to target and silence the expression of the YY1 gene. As a small interfering RNA (siRNA), it is used to transiently knockdown the YY1 gene in cell-based experiments. The core function of YY1 siRNA is to facilitate the investigation of the biological role of the YY1 transcription factor in various cellular processes.

Automatically generated - may contain errors

5 protocols using yy1 sirna

1

Silencing Transcription Factors in Esophageal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
ESCCAL-1 shRNA, WNT2 siRNA, YY1 siRNA, Myc siRNA, and their control shRNA or siRNAs were synthesized from GenePharma (Shanghai, China). EC109 and EC9706 cells were transfected using Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA) according to manufacturer’s instructions. Transfection efficacy was validated by RTq-PCR or western blot assay.
+ Open protocol
+ Expand
2

Optogenetic Regulation of A2aAR and YY1 in Astrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
pcDNA3.1/opto-a1AR-EYFP was a gift from Karl Deisseroth (Addgene plasmid #20947). A2aAR and YY1 siRNA were purchased from GenePharma (Shanghai, China). The sequence of A2aAR siRNA was 5′-AAACTTCTTCGTGGTATCTCT-3′ [42 (link)]. The sequence of YY1 siRNA was 5′-TTGTTCAATGTAGTCGTCG-3′, and the HDAC1 siRNA sequence was 5′-GTTGGAAGAGTTCTTCGGG-3′. Astrocytes were cultured on 6-well dishes, and 2 μg of plasmid or 200 nM siRNA was used to transfect the astrocytes using FuGENE® HD transfection reagent for 48 h. Treated cells were used for further study.
+ Open protocol
+ Expand
3

Silencing porcine YY1 gene expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
One siRNA that targeted the mRNA of the porcine YY1 gene (XM_021099699) was designed.
The sequences of the anti-YY1 siRNA and NC siRNA are as follows:

YY1-siRNA (sense): CCGAGUACAUGACAGGAAATT

YY1-siRNA (antisense): UUUCCUGUCAUGUACUCGGTT

NC-siRNA (sense): UUCUCCGAACGUGUCACGUTT

NC-siRNA (antisense): ACGUGACACGUUCGGAGAATT

Anti-YY1 siRNA and NC siRNA were synthesized by GenePharma (Shanghai, China).
Porcine fetal fibroblasts (PFF) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) complete medium containing 12% fetal bovine serum (Gibco) in a 10 cm diameter petri dish at 37 °C and 5% CO2. The cells were digested with trypsin after they were 90% confluent. siRNA transfection was performed using the transfection reagent Lipofectamine™ RNAiMAX (Invitrogen) according to the instructions. Forty-eight hours post-transfection, cells were collected for total RNA extraction and were stored at −80 °C for later use.
+ Open protocol
+ Expand
4

Versatile Cell Line Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this experiment, four cell lines of which THHL‐3 and HL‐7702 belong to human liver epithelial cells and HepG2 and SMMC‐7721 represent HCC cell lines were involved. All four cell lines were purchased from the ATCC Cell Biology Collection (Maryland, USA) and stored at –80°C. The Dulbecco's Modified Eagle Medium with 10% fetal bovine serum and 100 U/mL penicillin‐streptomycin was used to culture the cells in a chilled atmosphere of 5% CO2 at 37°C.
The CASC11 siRNAs, EIF4A3 siRNA, YY1 siRNA, negative control (NC) siRNAs, E2F1 overexpression plasmids pcDNA‐E2F1, NC plasmids pcDNA‐NC, and luciferase reporter vectors with wild or mutant CASC11 promoter were synthesized by GenePharma (Shanghai, China). The sequences are detailed in Table S1. The lipofectamine 2000 (Invitrogen Life Technologies, USA) was employed to accomplish the cell transfections as previously described.17
+ Open protocol
+ Expand
5

Silencing YY1 Using siRNA Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The YY1-siRNA, pIRES2-EGFP-YY1 and respective negative controls were purchased from GenePharma (Shanghai, China). The specific sequences of YY1 siRNA were as follows: (F) 5′-CAUGUCCAUUAUUCGUGATT-3′(R) 5′-UCACGAAUGGCCAUGTG-3′. A non-coding siRNA (Invitrogen, Carlsbad, CA, USA) was used as a negative control. Transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. Briefly, after trypsinization, cells were resuspended in an antibiotic-free medium and mixed with Opti-MEM (Gibco, Carlsbad, CA, USA) including 25 nM siRNA and Lipofectamine 2000. After incubation for 20 min at room temperature, cells were diluted with culture medium and seeded into a 60-mm dish. For cell viability assays, siRNA-transfected cells were re-seeded into a 48-well plate at 48 h after transfection. The silencing efficiency of V-ATPase V1A subunit siRNA was measured by the expression of mRNA and protein.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!